Countering the Problem of Falsified and Substandard Drugs
Countering the Problem of Falsified and Substandard Drugs

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2013-06-20

Total Pages: 377

ISBN-13: 0309269393

DOWNLOAD EBOOK

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Drug Safety in Developing Countries
Drug Safety in Developing Countries

Author: Yaser Mohammed Al-Worafi

Publisher: Academic Press

Published: 2020-06-03

Total Pages: 656

ISBN-13: 0128204125

DOWNLOAD EBOOK

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. - Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues - Describes current achievements of drug safety practice in developing countries - Addresses the challenges of drug safety in developing countries - Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Pharmaceutical Anti-Counterfeiting
Pharmaceutical Anti-Counterfeiting

Author: Mark Davison

Publisher: John Wiley & Sons

Published: 2011-07-26

Total Pages: 432

ISBN-13: 0470616172

DOWNLOAD EBOOK

This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.

Sick Crime
Sick Crime

Author: United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources

Publisher:

Published: 2006

Total Pages: 160

ISBN-13:

DOWNLOAD EBOOK

Counterfeit Drugs
Counterfeit Drugs

Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations

Publisher:

Published: 2015

Total Pages: 240

ISBN-13:

DOWNLOAD EBOOK

Counterfeit Medicines: Policy, economics, and countermeasures
Counterfeit Medicines: Policy, economics, and countermeasures

Author: Albert I. Wertheimer

Publisher: ILM Publications

Published: 2012

Total Pages: 156

ISBN-13: 1906799083

DOWNLOAD EBOOK

"Discusses the economic and financial consequences of pharmaceutical product counterfeiting and describes some of the measures that can be taken to counteract their impact"--Provided by publisher.

Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries

Author: Mohamed Izham Mohamed Ibrahim

Publisher: Academic Press

Published: 2017-10-24

Total Pages: 486

ISBN-13: 0128112298

DOWNLOAD EBOOK

Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries. While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face. - Examines key issues and challenges of pharmacy practice and the pharmaceutical sector specific to low- and middle-income countries - Compares pharmacy practice in developed and developing countries to highlight the unique challenges and opportunities of each - Provides a blueprint for the future of pharmacy in low- and middle-income countries, including patient-centered care, evidence-based care and promoting the role of the pharmacist for primary health care in these settings